Slowing down the body’s response to the invasion of infection may be a key “trick” coronavirus, told the Bloomberg Agency American virologist Shane Crotty.
“The trick is to avoid an initial congenital immune response over a significant period of time and, in particular, to avoid an early type I interferon response,” he said.
“Vector,” told about the formation of lifetime immunity to coronavirus.
Previously, researchers have already noted the association of COVID-19 with interferon deficiency: for example, it has been reported that its deficiency may be a decisive factor that leads to a severe course of the disease.
According to American scientists published in the journal Science, the use of synthetic interferons previously used to treat other diseases can be effective in the fight against coronavirus.
The study was also commented on by Alexander Heushen, head of the Genome Technology and Immunogenomics group at Radboud University Medical Center in Nijmegen. He noted that the use of interferon will only help fight COVID-19 in the early stages of the disease. In other cases, the course of the infection and the patient’s recovery will, he emphasized, depend on time.